Search

In Stock

Buy Feraccru (ferric maltol) Online

DISEASE INDICATIONS: Iron deficiency

MANUFACTURER: Shield Therapeutics

USAGE: Oral

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Swissmedic (CH)

Feraccru, known by its generic name Ferric Maltol, is a pharmaceutical medication used to treat iron deficiency anemia in adult patients with inflammatory bowel disease (IBD). It is a novel oral iron replacement therapy designed to help replenish iron levels in individuals who have difficulty absorbing iron through their gastrointestinal system.

$162.85

Clear
Compare

Feraccru, known by its generic name Ferric Maltol, is a pharmaceutical medication used to treat iron deficiency anemia in adult patients with inflammatory bowel disease (IBD). It is a novel oral iron replacement therapy designed to help replenish iron levels in individuals who have difficulty absorbing iron through their gastrointestinal system. Here is a detailed description of Feraccru (Ferric Maltol):

  1. Mechanism of Action: Feraccru contains ferric iron, which is essential for the production of hemoglobin, the oxygen-carrying component of red blood cells. Ferric Maltol is specifically formulated to enhance iron absorption in the gut. It is thought to be effective because maltol, a compound derived from malted barley, helps improve the solubility and absorption of ferric iron in the intestines. This allows the body to utilize the iron for red blood cell production.
  2. Indications: Feraccru is indicated for the treatment of iron deficiency anemia in adults with inflammatory bowel disease (IBD), such as Crohn’s disease and ulcerative colitis, who have not responded well to other oral iron supplements or who cannot tolerate them. It can help address anemia resulting from chronic gastrointestinal bleeding or impaired iron absorption due to IBD.
  3. Administration: Feraccru is available in capsule form and is typically taken orally. The dosage may vary depending on the severity of the anemia and the patient’s response to treatment. It is important to follow the prescribing physician’s instructions carefully.
  4. Effectiveness: Clinical studies have shown that Ferric Maltol can effectively increase hemoglobin levels and replenish iron stores in patients with iron deficiency anemia associated with inflammatory bowel disease. It offers an alternative to intravenous iron therapies, which may be less convenient and more invasive.
  5. Safety Profile: Like all medications, Feraccru may have potential side effects, including gastrointestinal symptoms such as diarrhea, constipation, and abdominal pain. However, it is generally well-tolerated. Patients should consult their healthcare providers if they experience any adverse reactions or concerns.
  6. Monitoring: Patients prescribed Feraccru may need periodic monitoring of their iron levels, hemoglobin levels, and overall response to treatment. This helps ensure that the medication is effectively addressing their anemia.
  7. Contraindications: Ferric Maltol is typically not recommended for patients with known hypersensitivity to the drug or those with iron overload disorders such as hemochromatosis.

It is essential for individuals with iron deficiency anemia related to inflammatory bowel disease to discuss their treatment options with a healthcare provider, who can provide personalized guidance on whether Feraccru (Ferric Maltol) is an appropriate and effective choice for their specific medical condition.

Package

56 capsules of 30 mg

Reviews

There are no reviews yet.

Write a review

Your email address will not be published. Required fields are marked *

Bestsellers

Buy Adakveo (crizanlizumab) Online

$1,844.95
(0 Reviews)
DISEASE INDICATIONS: Sickle Cell Disease MANUFACTURER: Novartis USAGE: Intravenous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Adakveo, with its active ingredient crizanlizumab, is a prescription medication used in the treatment of a specific medical condition known as sickle cell disease (SCD).

Buy Ultomiris (ravulizumab) Online

(0 Reviews)
MANUFACTURER: Alexion Pharmaceuticals USAGE: Intravenous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Pharmaceuticals and Medical Devices Agency (PMDA) Ultomiris, known by its generic name Ravulizumab, is a medication used to treat two rare and life-threatening blood disorders, namely paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).

Buy Cablivi (caplacizumab) Online

$4,125.96
(0 Reviews)
DISEASE INDICATIONS: Acquired thrombotic thrombocytopenic purpura (aTTP) MANUFACTURER: Ablynx NV USAGE: Intravenous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Health Canada Therapeutic Goods Administration (TGA) Cablivi, with its active ingredient caplacizumab, is a prescription medication used in the treatment of a rare and serious medical condition known as acquired thrombotic thrombocytopenic purpura (aTTP).

Buy Inrebic (fedratinib) Online

$5,242.36
(0 Reviews)
DISEASE INDICATIONS: Myelofibrosis MANUFACTURER: Impact Biomedicines, Inc. USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Inrebic, known by its generic name Fedratinib, is a medication used to treat certain rare bone marrow disorders, specifically myelofibrosis.

Buy Oxbryta (voxelotor) Online

$33,074.12
(0 Reviews)
ISEASE INDICATIONS: Sickle Cell Disease MANUFACTURER: Global Blood Therapeutics, Inc. USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Oxbryta, known by its generic name Voxelotor, is a pharmaceutical medication used to treat a rare genetic blood disorder called sickle cell disease (SCD).

Buy Evrenzo (Roxadustat) Online

From $171.42
(0 Reviews)
DISEASE INDICATIONS: Anemia MANUFACTURER: Astellas Pharma Inc. FibroGen USAGE: Intravenous MEDICINE APPROVED BY: European Medical Agency (EMA) Pharmaceuticals and Medical Devices Agency (PMDA) Evrenzo, known by its generic name Roxadustat, is a pharmaceutical medication that belongs to a class of drugs called HIF-PH (Hypoxia-Inducible Factor Prolyl Hydroxylase) inhibitors. This innovative medication is primarily used to treat certain types of anemia, particularly those associated with chronic kidney disease (CKD) and inflammation.

Buy Givlaari (givosiran) Online

(0 Reviews)
DISEASE INDICATIONS: Acute Hepatic Porphyria (AHP) MANUFACTURER: Alnylam Pharmaceuticals USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Pharmaceuticals and Medical Devices Agency (PMDA) Givlaari, known by its generic name Givosiran, is a pharmaceutical medication used to treat a rare genetic disorder called acute hepatic porphyria (AHP). This innovative medication represents a significant advancement in the management of this condition, which is characterized by recurrent, severe attacks of abdominal pain, neurological symptoms, and potential life-threatening complications.

Back to Top
Product has been added to your cart